Stay updated on Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition, saying federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T21:59:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-14T22:02:35.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-07T22:15:36.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the previous study content. This blocks access to the RELATIVITY-047 study details and related information.
    Difference
    18%
    Check dated 2026-09-23T21:53:46.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision metadata on the page was updated from v3.6.6 to v3.7.0, indicating a newer version of the page. This is a maintenance update and does not modify the study content or results.
    Difference
    0.0%
    Check dated 2026-09-16T22:09:04.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The melanoma term, the related topics header, and the MedlinePlus Genetics link were removed. This reduces disease-specific context and access to a related health resource on the study page.
    Difference
    0.1%
    Check dated 2026-09-09T21:38:23.000Z thumbnail image

Stay in the know with updates to Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab Combo VS Nivolumab Alone in Melanoma Clinical Trial page.